Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.

Psychosis and Schizophrenia

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia

Neuroimage Clin

Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Pezawas L, Praschak-Rieder N, Willeit M

doi: 10.1016/j.nicl.2021.102813

Psychosis and Schizophrenia

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Lancet Psychiatry.

Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, Li C, Davis JM, Leucht S

doi: 10.1016/S2215-

RECOMMENDED

Psychosis and Schizophrenia

Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion

Eur Arch Psychiatry Clin Neurosci.

Kleineidam L, Frommann I, Ruhrmann S, Klosterkötter J, Brockhaus-Dumke A, Wölwer W, Gaebel W, Maier W, Wagner M, Ettinger U

doi: 10.1007/s00406-

Psychosis and Schizophrenia

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Prog Neuropsychopharmacol Biol Psychiatry.

Huang M, Yu L, Pan F, Lu S, Hu S, Hu J, Chen J, Jin P, Qi H, Xu Y

doi: 10.1016/

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia

JAMA Psychiatry.

Kochunov P, Coyle TR, Rowland LM, Jahanshad N, Thompson PM, Kelly S, Du X, Sampath H, Bruce H, Chiappelli J, Ryan M, Fisseha F, Savransky A, Adhikari B, Chen S, Paciga SA, Whelan CD, Xie Z, Hyde CL, Chen X, Schubert CR, O'Donnell P, Hong LE

doi: 10.1001/jamapsychiatry.

Psychosis and Schizophrenia

Cognitive capacity similarly predicts insight into symptoms in first- and multiple-episode psychosis

Schizophr Res.

Sauvé G, Kline RB, Shah JL, Joober R, Malla A, Brodeur MB, Lepage M

doi: 10.1016/j.schres.2018.11.013.

Aging and Cognitive FunctionsPsychosis and Schizophrenia

From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline

J Psychiatr Res.

Carrión RE, Walder DJ, Auther AM, McLaughlin D, Zyla HO, Adelsheim S, Calkins R, Carter CS, McFarland B, Melton R, Niendam T, Ragland JD, Sale TG, Taylor SF, McFarlane WR, Cornblatt BA

doi: 10.1016/

Aging and Cognitive FunctionsAlzheimer’s Disease

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

JAMA Neurol.

Wolk AD, Sadowsky C, Safirstein B, Rinne JO, Duara J, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F

doi: 10.1001/

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables

Prog Neuropsychopharmacol Biol Psychiatry.

de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F

doi: 10.1016/j.pnpbp.2017.09.002.

Related content

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia

Cognitive capacity similarly predicts insight into symptoms in first- and multiple-episode psychosis

From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables